Eye Care - BRICS

  • BRICS
  • In 2024, the revenue in the Eye Care market market in BRICS amounts to US$0.78bn.
  • This market is expected to grow annually by 3.36% (CAGR 2024-2029).
  • When comparing globally, the in the United States generates the highest revenue with US$1,256.00m in 2024.
  • In terms of per person revenues, in BRICS generates US$0.24 in 2024.
  • Brazil's eye care market is experiencing significant growth due to increasing awareness about the importance of eye health.

Key regions: Australia, Japan, Brazil, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care market in BRICS is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this growth.Customer preferences in the Eye Care market in BRICS are shifting towards a greater emphasis on preventive care and overall eye health. Customers are becoming more aware of the importance of regular eye examinations and are seeking out products and services that can help maintain and improve their vision. This shift in preferences is driven by a growing middle class and an aging population, both of which are more concerned with maintaining their health and well-being.Trends in the market are also driving the growth of the Eye Care market in BRICS. One trend is the increasing adoption of contact lenses and eyeglasses as fashion accessories. Customers are now choosing eyewear that not only corrects their vision but also complements their personal style. This trend has led to the emergence of a wide range of fashionable eyewear brands and designs, further fueling the growth of the market.Another trend is the rising demand for advanced eye care technologies and treatments. Customers in BRICS countries are increasingly seeking out innovative solutions for common eye conditions such as myopia, presbyopia, and cataracts. This has led to the development and adoption of new technologies such as laser eye surgery and advanced intraocular lenses. The availability of these advanced treatments is driving the growth of the Eye Care market in BRICS.Local special circumstances also play a role in the development of the Eye Care market in BRICS. Each country in the BRICS group has its own unique healthcare system and regulations, which can impact the availability and affordability of eye care services and products. For example, in some countries, access to eye care services may be limited in rural areas, leading to a higher demand for mobile eye clinics or telemedicine solutions. Additionally, government policies and initiatives aimed at promoting eye health can also influence the growth of the market.Underlying macroeconomic factors are also contributing to the growth of the Eye Care market in BRICS. Economic growth and increasing disposable incomes in these countries are driving the demand for eye care products and services. As more people are able to afford eye care, the market is expanding. Additionally, urbanization and changing lifestyles are leading to an increase in the prevalence of eye conditions such as myopia and dry eye syndrome, further driving the demand for eye care solutions.In conclusion, the Eye Care market in BRICS is experiencing significant growth and development due to shifting customer preferences, emerging market trends, local special circumstances, and underlying macroeconomic factors. As customers become more aware of the importance of eye health and seek out innovative solutions, the market is expected to continue to grow in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)